Atomoxetine in abstinent cocaine users: Sex differences
2017
DeVito, Elise E. | Herman, Aryeh I. | Konkus, Noah S. | Zhang, Huiping | Sofuoglu, Mehmet
Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40mg and 80mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1].
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
Data in Brief
卷
14
页码
566
- 572
ISSN
2352-3409
出版者
Springer Netherlands
其它主题
Cognition; Placebos
语言
英语
类型
Journal Article; Text
2024-02-28
MODS